CANKADO GmbH empowers patients, supports physicians, and innovates healthcare. Founded from a research project at LMU Munich led by Prof. Dr. Timo Schinköthe, CANKADO is a leading company in digital therapeutics shaping the future of healthcare through innovative solutions. Their mission is to aid patients with chronic conditions and empower them to take control of their healthcare. Their digital therapeutics, such as PRO-React, improve patients' quality of life and ease healthcare professionals' work.

They develop innovative digital health solutions, collaborate with international medical experts and pharmaceutical companies, and conduct clinical studies to validate the benefits of digital healthcare technologies. CANKADO serves international markets with presence in Germany, India, and Argentina, partnering with renowned institutions to be a trusted healthcare industry partner.

PRO-React is the only digital therapeutic system with clinically validated efficacy. The company has strong partnerships with leading pharmaceutical firms and decades of scientific research and development experience. Their vision focuses on expanding their digital solutions portfolio, advancing technology, and making a sustainable global impact in healthcare.